The UK Diabetes Devices Market size was valued at USD 800 Million in 2023 and the total UK Diabetes Devices revenue is expected to grow at a CAGR of 5.96% from 2024 to 2030, reaching nearly USD 1200 Million.UK Diabetes Devices Market Overview-
This report analyses the UK Diabetes Devices market and covers anticipated trends, technological advancements, and potential disruptions that shape the market. It assesses market size, growth, economic factors, regulations, and commercial drivers. The competitive landscape is analyzed, highlighting differentiation among key operators and drawing on historical data and industry insights and the report forecasts sector. The economic downturn prompted this analysis and revealed the UK diabetes devices industry resilience challenges. Factors such as the prevalence of diabetes and environmental concerns drive increased awareness and improved diagnostic methods, a growing diabetes population, and a Sustainability focus. The report aims to equip stakeholders with crucial, concise information for informed decision-making in this dynamic sector. The targeted audiences include People with diabetes, Healthcare professionals, Secondary Audiences, Government agencies, policymakers, and pharmaceutical companies in the UK diabetes devices industry.To know about the Research Methodology :- Request Free Sample Report Increasing Diabetes Prevalence Impact on the UK Diabetes Devices Market The increasing diabetes patient population drives demand for self-monitoring and insulin delivery devices and increases the UK Diabetes Devices market revenue. A diverse patient's needs from newly diagnosed to long-term complications and varying diabetes types, create opportunities for position players and device innovation, fostering UK Diabetes Devices industry growth and adaptation to specific requirements. The growing prevalence of diabetes prompts increased healthcare expenditure, potentially directing more funds to diabetes management and device reimbursement. In healthcare resource constraints and emphasis on cost-effectiveness drive the development of affordable devices, promote generic alternatives, and highlight the long-term cost benefits of effective diabetes management through devices.
The increasing awareness of the diabetes problem directs the UK Diabetes Devices market focus toward early detection and prevention and highlighting devices for prediabetes screening, continuous glucose monitoring, and tools for promoting lifestyle changes. As the patient population increases, there is a demand for personalized care, data-driven insights, and remote monitoring solutions, rising patient-physician communication and care coordination.
UK Diabetes Devices Market Segment Analysis
Based on Type, the Blood glucose monitoring systems segment held the largest market share of about 60% in the UK Diabetes Devices Market in 2023. According to the MMR analysis, the segment is further expected to grow at a CAGR of 3.12% during the forecast period. It stands out as the dominant segment within the UK Diabetes Devices Market thanks to its rapid technological advancement and growing adoption of smart devices with data connectivity and integration.The imperative for accurate blood glucose monitoring fuels continuous innovation in Blood Glucose Monitoring Systems (BGMS) technology. Developments such as Continuous Glucose Monitoring (CGM) systems, Flash Glucose Monitoring (FGM) devices, and smart technology integration shape the UK Diabetes Devices market. In specific segments: 1. Self-Monitoring Blood Glucose Monitoring Systems (SMBGMS): With the rise of CGM and FGM, SMBGMS persist as the most widely used due to affordability and user-friendliness, fostering a growing UK Diabetes Devices market for associated components. 2. Insulin Delivery Devices: Accurate BGMS data impacts insulin dosing decisions, benefiting insulin pumps with real-time CGM data for precise control, while SMBGMS data guides insulin pen and syringe usage. 3. Digital Health Integration: BGMS data integration with digital health platforms and telehealth services enables remote monitoring, personalized care plans, and increased communication between patients and healthcare providers. In addition, determining a specific profit for the Blood glucose monitoring systems segment in the UK diabetes devices market is challenging. However, assessing the market size, growth, and profit influencing factors provides insight into its profitability and potential growth.
UK Diabetes Devices Market Scope : Inquire Before Buying
UK Diabetes Devices Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 800 Mn. Forecast Period 2024 to 2030 CAGR: 5.96% Market Size in 2030: US $ 1200 Mn. Segments Covered: by Type Blood glucose monitoring systems Self-monitoring blood glucose monitoring systems Continuous glucose monitoring systems Test strips/Test papers Lancets/Lancing Devices Insulin Delivery Devices Insulin pumps Insulin pens Insulin syringes and needles Diabetes management mobile applications by End User Hospitals & Specialty Clinics Self & Home Care UK Diabetes Devices Market, Key Players are
1. Magstim (UK) 2. Deltex Medical (UK) 3. Johnson & Johnson 4. DarioHealth 5. Medtronic 6. Philipps Healthcare 7. Dexcom 8. Roche Diabetes Care 9. Medtronic plc 10. Abbott Laboratories 11. Becton, Dickinson and Company (BD) 12. Sanofi 13. Novo Nordisk 14. Ascensia Diabetes Care 15. Insulet Corporation Frequently Asked Questions: 1. What is the growth rate of Market? Ans: The Market is growing at a CAGR of 5.96% during forecasting period 2024-2030. 2. What is scope of the Market report? Ans: Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 3. Who are the key players in Market? Ans: The important key players in the Market are – Magstim (UK), Deltex Medical (UK), Johnson & Johnson, DarioHealth, Medtronic, Philipps Healthcare, Dexcom, Roche Diabetes Care, Medtronic plc, Abbott Laboratories, Becton, Dickinson and Company (BD), Sanofi, Novo Nordisk, Ascensia Diabetes Care, Insulet Corporation. 4. What is the study period of this Market? Ans: The UK Diabetes Devices Market is studied from 2023 to 2030.
1. UK Diabetes Devices Market Introduction 1.1 Study Assumption and Market Definition 1.2 Scope of the Study 1.3 Executive Summary 2. UK Diabetes Devices Market Overview 2.1 Emerging Technologies 2.2 Market Projections 2.3 Strategic Recommendations 3. UK Diabetes Devices Market Patient Demographics 3.1 Prevalence of Diabetes in the UK 3.2 Age and Gender Distribution 3.3 Impact of Lifestyle Factors 4. UK Diabetes Devices Market: Dynamics 4.1.1 Market Drivers 4.1.2 Market Restraints 4.1.3 Market Opportunities 4.1.4 Market Challenges 4.2 PORTER’s Five Forces Analysis 4.3 PESTLE Analysis 4.4 Value Chain Analysis 4.5 Regulatory Landscape 4.6 Analysis of Government Schemes and Initiatives for the UK Diabetes Devices Industry 4.7 The Pandemic and Redefining of The UK Diabetes Devices Industry Landscape 5. UK Diabetes Devices Market: Market Size and Forecast by Segmentation (Value) (2023-2030) 5.1 UK Diabetes Devices Market Size and Forecast, by Type (2023-2030) 5.1.1 Blood glucose monitoring systems 5.1.2 Self-monitoring blood glucose monitoring systems 5.1.3 Continuous glucose monitoring systems 5.1.4 Test strips/Test papers 5.1.5 Lancets/Lancing Devices 5.1.6 Insulin Delivery Devices 5.1.7 Insulin pumps 5.1.8 Insulin pens 5.1.9 Insulin syringes and needles 5.1.10 Diabetes Management Mobile Applications 5.2 UK Diabetes Devices Market Size and Forecast, by End-User (2023-2030) 5.2.1 Hospitals & Specialty Clinics 5.2.2 Self & Home Care 6. UK Diabetes Devices Market: Competitive Landscape 6.1 MMR Competition Matrix 6.2 Competitive Landscape 6.3 Key Players Benchmarking 6.3.1 Company Name 6.3.2 Service Segment 6.3.3 End-user Segment 6.3.4 Revenue (2023) 6.3.5 Company Locations 6.4 Leading UK Waste Management and Recycling Companies, by market capitalization 6.5 Market Structure 6.5.1 Market Leaders 6.5.2 Market Followers 6.5.3 Emerging Players 6.6 Mergers and Acquisitions Details 7. Company Profile: Key Players 7.1 Magstim (UK) 7.1.1 Company Overview 7.1.2 Business Portfolio 7.1.3 Financial Overview 7.1.4 SWOT Analysis 7.1.5 Strategic Analysis 7.1.6 Scale of Operation (small, medium, and large) 7.1.7 Details on Partnership 7.1.8 Regulatory Accreditations and Certifications Received by Them 7.1.9 Awards Received by the Firm 7.1.10 Recent Developments 7.2 Deltex Medical (UK) 7.3 Johnson & Johnson 7.4 DarioHealth 7.5 Medtronic 7.6 Philipps Healthcare 7.7 Dexcom 7.8 Roche Diabetes Care 7.9 Medtronic plc 7.10 Abbott Laboratories 7.11 Becton, Dickinson, and Company (BD) 7.12 Sanofi 7.13 Novo Nordisk 7.14 Ascensia Diabetes Care 7.15 Insulet Corporation 8. Key Findings 9. Industry Recommendations 10. Terms and Glossary 11. UK Diabetes Devices Market: Research Methodology